Cargando...
Nucleolin-binding by ErbB2 enhances tumorigenicity of ErbB2-positive breast cancer
ErbB2 is an important member of the ErbB family, which activates growth and proliferation signaling pathways. ErbB2 is often overexpressed in various malignancies, especially in breast cancer, and is a common target for anti-cancer drugs. Breast cancer is currently one of the leading mortality cause...
Guardado en:
| Publicado en: | Oncotarget |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Impact Journals LLC
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5323158/ https://ncbi.nlm.nih.gov/pubmed/27542246 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11323 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|